The human TREM-1 ELISA test quantifies human TREM-1 in serum, plasma or cell culture media. The test will only recognize natural and recombinant TREM-1 Hu. Method principle The ELISA sandwich test...
The human TREM-1 ELISA test quantifies human TREM-1 in serum, plasma or cell culture media. The test will only recognize natural and recombinant TREM-1 Hu. Method Principle The ELISA Human TREM-1 solid phase sandwich test (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
TREM1 (trigger receptor expressed on myeloid cells 1) is an Ig superfamily receptor that amplifies neutrophil and monocytic inflammatory responses triggered by bacterial and fungal infections by stimulating the release of chemokines and pro-inflammatory cytokines, and the increase in surface expression of cell activation markers. Other TREM-related TREM1 proteins such as TREM2 are thought to act to modulate the inflammatory response. TREM1 has also been associated with chronic inflammatory bowel disease, resulting in increased production of TNF, d-IL-6, d-IL-8 and MCP-1.
Sensitivity
Sensitivity of the dosage: 70 pg/ml.
Measurement range
Dose range: 68.59-50.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15495163 |
| Specifications |
| Accession number | Q9NP99 |
| Dose range | 68.59-50.000 pg/ml |
| Sensitivity of the dosage | 70 pg/ml |
| Calibration range | 70 pg/ml to 50000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Chemiokine & receptors |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following cytokines tested: angiogenin, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, leptine (OB), MCP- |
| Sufficient for | 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 54210 |
| Gene symbol(s) | CD354,TREM-1 |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Immunology |
| Synonym | CD354, TREM-1 |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHTREM1 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.